KuopioHealth is a network of health professionals committed to advancing health technology expertise, research, business life and awareness of the area
Femma5 is developing an artificial pancreas called Femma5 Insulin Dosage Assistant that automatically regulates insulin levels based on continuous glucose monitoring, eliminating the need for finger pricks and manual insulin dosing calculations. They are seeking investors to fund clinical trials of the device and development of a holistic diabetes management platform. The company's team has extensive experience in diabetes care, medical device R&D and manufacturing, and commercializing healthcare products.
EUPATI launch meeting - Michel Goldman IMIjangeissler
The Innovative Medicines Initiative promotes public-private partnerships through a 2 billion euro joint funding program between the European Union and the pharmaceutical industry. The initiative aims to overcome drug development bottlenecks, increase biopharmaceutical investments in Europe, and contribute to public health. Major projects under the initiative include developing patient-reported outcomes, predicting biomarkers, novel drug safety approaches, and tools for translational research.
Wedar Group is a biotechnology company founded in 1998 that operates in the nutraceutical ingredients space. It represents branded nutritional and dietary ingredients from the US and Europe. Wedar's vision is to care for customers accurately and reasonably through exclusive representation. It focuses on branding, science, and emerging markets. Wedar invests in R&D, technical seminars, and advertising. It has over 1000 industry clients in China and Taiwan and represents brands like Phytosure. Wedar also operates its own retail stores and brands in Taiwan, selling vitamins, nutrition, skincare and more through various distribution channels.
Sustainable Supply Chains in the Global Health Aid MarketUN SPHS
Anne Gadegaard, Global Senior Advisor of Novo Nordisk has delivered a presentation highlighting the policy of Triple Bottom Line: Financially Responsible, Socially Responsible, Environmentally Responsible at the dialogue on “Fostering Sustainable Procurement: How Procurers Can Change the Global Health Sector” in UN City, Copenhagen.
The document discusses carbon labeling, which involves quantifying and displaying the carbon footprint of products. It outlines the benefits of carbon labels, challenges in implementation, and case studies of companies that have adopted carbon labeling, such as Max Burger restaurants in Sweden. The presentation covers what carbon labels are, why they are important for reducing greenhouse gas emissions, how they can potentially impact consumer and business behavior, and challenges to widespread adoption.
This document summarizes research on growing Omega Pharma's baby care category and brands in Belgium. It discusses internal research from colleagues and IMS data showing good performance of their Galenco and Bibi brands. It also analyzes a survey finding most purchases are from pharmacies and consumers prefer brands for reliability. It concludes early penetration in hospitals is important and discusses opportunities like expanding Galenco's product range and addressing gaps for Bibi soothers. The discussion notes limitations like lack of internal data and biases in the survey.
IDT Biologika is a biologics and vaccine manufacturing company with two business models: contract manufacturing and their own animal health products. They have 1,700 employees, generate over €200 million in annual revenues, and have invested €300 million since 1993, including €100 million between 2011-present. IDT works with customers and partners around the world and has an investment grade rating, with a corporate strategy focused on globalization and industrialization to support further growth.
UNDP Greening Health Systems Specialist Lorea Coronado-Garcia delivered a presentation at CleanMed 2017 on May 17, 2017 in Minnesota, U.S. Ms. Garcia presented the SPHS and the work UNDP has done as host agency of the SPHS.
The presentation focused on the U.N. approach on greening the global health sector, with the final aim of improving human health and well-being.
Femma5 is developing an artificial pancreas called Femma5 Insulin Dosage Assistant that automatically regulates insulin levels based on continuous glucose monitoring, eliminating the need for finger pricks and manual insulin dosing calculations. They are seeking investors to fund clinical trials of the device and development of a holistic diabetes management platform. The company's team has extensive experience in diabetes care, medical device R&D and manufacturing, and commercializing healthcare products.
EUPATI launch meeting - Michel Goldman IMIjangeissler
The Innovative Medicines Initiative promotes public-private partnerships through a 2 billion euro joint funding program between the European Union and the pharmaceutical industry. The initiative aims to overcome drug development bottlenecks, increase biopharmaceutical investments in Europe, and contribute to public health. Major projects under the initiative include developing patient-reported outcomes, predicting biomarkers, novel drug safety approaches, and tools for translational research.
Wedar Group is a biotechnology company founded in 1998 that operates in the nutraceutical ingredients space. It represents branded nutritional and dietary ingredients from the US and Europe. Wedar's vision is to care for customers accurately and reasonably through exclusive representation. It focuses on branding, science, and emerging markets. Wedar invests in R&D, technical seminars, and advertising. It has over 1000 industry clients in China and Taiwan and represents brands like Phytosure. Wedar also operates its own retail stores and brands in Taiwan, selling vitamins, nutrition, skincare and more through various distribution channels.
Sustainable Supply Chains in the Global Health Aid MarketUN SPHS
Anne Gadegaard, Global Senior Advisor of Novo Nordisk has delivered a presentation highlighting the policy of Triple Bottom Line: Financially Responsible, Socially Responsible, Environmentally Responsible at the dialogue on “Fostering Sustainable Procurement: How Procurers Can Change the Global Health Sector” in UN City, Copenhagen.
The document discusses carbon labeling, which involves quantifying and displaying the carbon footprint of products. It outlines the benefits of carbon labels, challenges in implementation, and case studies of companies that have adopted carbon labeling, such as Max Burger restaurants in Sweden. The presentation covers what carbon labels are, why they are important for reducing greenhouse gas emissions, how they can potentially impact consumer and business behavior, and challenges to widespread adoption.
This document summarizes research on growing Omega Pharma's baby care category and brands in Belgium. It discusses internal research from colleagues and IMS data showing good performance of their Galenco and Bibi brands. It also analyzes a survey finding most purchases are from pharmacies and consumers prefer brands for reliability. It concludes early penetration in hospitals is important and discusses opportunities like expanding Galenco's product range and addressing gaps for Bibi soothers. The discussion notes limitations like lack of internal data and biases in the survey.
IDT Biologika is a biologics and vaccine manufacturing company with two business models: contract manufacturing and their own animal health products. They have 1,700 employees, generate over €200 million in annual revenues, and have invested €300 million since 1993, including €100 million between 2011-present. IDT works with customers and partners around the world and has an investment grade rating, with a corporate strategy focused on globalization and industrialization to support further growth.
UNDP Greening Health Systems Specialist Lorea Coronado-Garcia delivered a presentation at CleanMed 2017 on May 17, 2017 in Minnesota, U.S. Ms. Garcia presented the SPHS and the work UNDP has done as host agency of the SPHS.
The presentation focused on the U.N. approach on greening the global health sector, with the final aim of improving human health and well-being.
Finn Medi Presentation study visit (Life Sciences Sector)TR3S PROJECT
Description of the FinnMedi company, an internationally operating company located in Finland and providing services related to research commercialization, business development and clinical research in the Life Sciences sector.
The National Institute for Health Research Collaboration for Leadership in Ap...Richard Harding
This document discusses using funding and partnerships to promote innovation in healthcare technology. It highlights projects in the UK that received funding to develop new technologies, including a children's hospital that leveraged over £13 million for an innovation center. It also describes a competition that provided £500,000 to pilot adoption of new technologies. The document outlines European partnerships and events between countries to support collaboration. It promotes an eHealth cluster to connect businesses, healthcare organizations, and academics. Finally, it discusses challenges of introducing new technologies and the need for organizational changes to accommodate disruptions.
ENoLL President Tuija Hirvikoski presented the European Network of Living Lab's vision on global opportunities through Living Labs at Cantillon 2017 event that was hosted in Ireland. Content of the presentation:
- strategy of Living Labs, how Living Labs work, ENoLL memberhsip and the 11th wave
- OI2 (open innovation)
- OpenLivingLab Days 2017
- LLs as Local Open Innovation
Ecosystems
- Living Lab examples (Finland - Laurea UAS)
Presentation of ENoLL President Tuija Hirvikoski on: Making most out of digitalization and citizen engagement for better solutions and faster market launch - at the Smart, Smarter, Helsinki Region
Implementation of the RIS3-strategies on 11.10.2016
Presentation "Innovating for Health and Well-being" at WHO International Healthy Cities conference, Athens, Greece, 25/OCT/2014, Arto Holopainen, Development Director, Kuopio Innovation Ltd.
Introduction: Digital Innovation Lead for the Women's and Children's VanguardRichard Harding
The document provides information on Richard Harding's experience with digital innovation and 10 innovations he implemented in 5 minutes. It discusses projects he worked on including providing funding to help leverage over £13 million for an institute and innovation center at Alder Hey Children's Hospital. It also summarizes a STOPandGO project that devised a procurement process to test public procurement of innovation across 7 procurers in 4 countries totaling €17 million. Additional sections cover innovation scouting, events to support collaboration, and digital healthcare platforms and apps.
This document outlines the goals and activities of an organization aimed at spreading innovation in healthcare to improve health outcomes and economic growth. The key points are:
1) The organization aims to spread innovation across the healthcare system, boost the economy through industry growth, and improve equal access to innovative technologies.
2) Activities include supporting the adoption of innovations, developing collaborations between sectors, highlighting opportunities, and bringing together multiple funding streams in the region.
3) The vision is for the region to become a preferred location for healthcare research, trials, collaboration and investment.
TCIOceania15 WelfareTech - Towards IndustrialisationTCI Network
WelfareTech is a Danish association established in 2010 to promote collaboration between businesses, hospitals, universities, and public authorities on developing intelligent solutions for healthcare and homecare services. It has 189 member organizations, including 94 companies. WelfareTech aims to address the challenges posed by Denmark's aging population through innovation in areas like telemedicine, robotics, and ICT. Its strategy for internationalization includes mapping clusters in other countries for collaboration, participating in EU innovation projects, and coordinating members' involvement in export promotion activities and international trade fairs. The goal is to help Danish companies expand into new overseas healthcare and welfare technology markets.
A presentation on the Uppsala biotech cluster and its cluster organization - Uppsala BIO. In this presentation, Uppsala BIO is seen as an agent of change in terms of its strategy and efforts to improve the competitiveness of the Uppsala biotech cluster.
Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
The document discusses innovation and the work of the Innovation Agency. It summarizes the agency's support for businesses, including engaging with 543 companies, providing intensive support to 81 companies, and helping create or safeguard over 100 jobs. It also describes the agency's efforts to foster collaboration through events, awards, and aligning with innovation hubs. The agency provides £500k in funding to pump prime adoption of new technologies and supports challenges to NHS procurement requirements to introduce innovation.
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...I MT
EIT Health is a network of health innovators backed by the European Union. It supports innovations in healthcare through three main programs: Innovation, Education, and Acceleration. The document provides information on EIT Health's activities in France, including its partners in different regions and industries. It also summarizes some of EIT Health's past successes in supporting new technologies and businesses, as well as training programs. Attendees of the event are encouraged to discuss project ideas and find potential partners.
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
The document discusses the Innovation Exchange and SBRI Healthcare programs which aim to accelerate the development and adoption of innovative healthcare solutions in England. It provides background on Karen Livingstone, the director of the programs. It then outlines key forces shaping global healthcare and describes the 15 Academic Health Science Networks that work locally and nationally to drive innovation adoption across England. The rest of the document details how the Innovation Exchange identifies healthcare needs and supports companies through funding competitions, needs assessments, and providing support to help ready solutions for adoption across the NHS. It provides examples of companies it has supported in areas like patient engagement, chronic condition management, and early disease detection.
EPIS meeting - Dr Derick Mitchell - October 2017ipposi
Derick Mitchell gave a talk on sustaining patient engagement resources through public-private platforms. Some key points:
1. He discussed IPPOSI, a patient-led organization that advocates for patient involvement in health innovation and research.
2. Patient organizations and industry can interact by moving past compliance and instead measuring the value of their interactions through trust and transparency.
3. Generating patient-based evidence through patient registries, mobile apps, and other tools can provide cost-effective, patient-relevant data to inform decision making.
Overview of Kuopio Innovation and Kuopio Science Park, as well as Region's Health Cluster smart speciliation. Senior Advisor Arto Holopainen, Kuopio Innovation Ltd.
Kuopio Innovation is a business developer in Kuopio, Finland that helps innovative organizations through combining ideas, experts, and new ways of thinking. It operates in the Kuopio region, home to the Kuopio Science Park which has over 240 enterprises and around 20,000 people working in fields like health, security, and ICT. Kuopio Innovation provides services like business incubation, helping entrepreneurs develop their ideas and access funding and networks. It also facilitates collaboration between different organizations in the region to foster innovation.
Finn Medi Presentation study visit (Life Sciences Sector)TR3S PROJECT
Description of the FinnMedi company, an internationally operating company located in Finland and providing services related to research commercialization, business development and clinical research in the Life Sciences sector.
The National Institute for Health Research Collaboration for Leadership in Ap...Richard Harding
This document discusses using funding and partnerships to promote innovation in healthcare technology. It highlights projects in the UK that received funding to develop new technologies, including a children's hospital that leveraged over £13 million for an innovation center. It also describes a competition that provided £500,000 to pilot adoption of new technologies. The document outlines European partnerships and events between countries to support collaboration. It promotes an eHealth cluster to connect businesses, healthcare organizations, and academics. Finally, it discusses challenges of introducing new technologies and the need for organizational changes to accommodate disruptions.
ENoLL President Tuija Hirvikoski presented the European Network of Living Lab's vision on global opportunities through Living Labs at Cantillon 2017 event that was hosted in Ireland. Content of the presentation:
- strategy of Living Labs, how Living Labs work, ENoLL memberhsip and the 11th wave
- OI2 (open innovation)
- OpenLivingLab Days 2017
- LLs as Local Open Innovation
Ecosystems
- Living Lab examples (Finland - Laurea UAS)
Presentation of ENoLL President Tuija Hirvikoski on: Making most out of digitalization and citizen engagement for better solutions and faster market launch - at the Smart, Smarter, Helsinki Region
Implementation of the RIS3-strategies on 11.10.2016
Presentation "Innovating for Health and Well-being" at WHO International Healthy Cities conference, Athens, Greece, 25/OCT/2014, Arto Holopainen, Development Director, Kuopio Innovation Ltd.
Introduction: Digital Innovation Lead for the Women's and Children's VanguardRichard Harding
The document provides information on Richard Harding's experience with digital innovation and 10 innovations he implemented in 5 minutes. It discusses projects he worked on including providing funding to help leverage over £13 million for an institute and innovation center at Alder Hey Children's Hospital. It also summarizes a STOPandGO project that devised a procurement process to test public procurement of innovation across 7 procurers in 4 countries totaling €17 million. Additional sections cover innovation scouting, events to support collaboration, and digital healthcare platforms and apps.
This document outlines the goals and activities of an organization aimed at spreading innovation in healthcare to improve health outcomes and economic growth. The key points are:
1) The organization aims to spread innovation across the healthcare system, boost the economy through industry growth, and improve equal access to innovative technologies.
2) Activities include supporting the adoption of innovations, developing collaborations between sectors, highlighting opportunities, and bringing together multiple funding streams in the region.
3) The vision is for the region to become a preferred location for healthcare research, trials, collaboration and investment.
TCIOceania15 WelfareTech - Towards IndustrialisationTCI Network
WelfareTech is a Danish association established in 2010 to promote collaboration between businesses, hospitals, universities, and public authorities on developing intelligent solutions for healthcare and homecare services. It has 189 member organizations, including 94 companies. WelfareTech aims to address the challenges posed by Denmark's aging population through innovation in areas like telemedicine, robotics, and ICT. Its strategy for internationalization includes mapping clusters in other countries for collaboration, participating in EU innovation projects, and coordinating members' involvement in export promotion activities and international trade fairs. The goal is to help Danish companies expand into new overseas healthcare and welfare technology markets.
A presentation on the Uppsala biotech cluster and its cluster organization - Uppsala BIO. In this presentation, Uppsala BIO is seen as an agent of change in terms of its strategy and efforts to improve the competitiveness of the Uppsala biotech cluster.
Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
The document discusses innovation and the work of the Innovation Agency. It summarizes the agency's support for businesses, including engaging with 543 companies, providing intensive support to 81 companies, and helping create or safeguard over 100 jobs. It also describes the agency's efforts to foster collaboration through events, awards, and aligning with innovation hubs. The agency provides £500k in funding to pump prime adoption of new technologies and supports challenges to NHS procurement requirements to introduce innovation.
Colloque IMT - 15/10/2019 - Healthcare 4.0 – « EIT Health : un tremplin europ...I MT
EIT Health is a network of health innovators backed by the European Union. It supports innovations in healthcare through three main programs: Innovation, Education, and Acceleration. The document provides information on EIT Health's activities in France, including its partners in different regions and industries. It also summarizes some of EIT Health's past successes in supporting new technologies and businesses, as well as training programs. Attendees of the event are encouraged to discuss project ideas and find potential partners.
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
The document discusses the Innovation Exchange and SBRI Healthcare programs which aim to accelerate the development and adoption of innovative healthcare solutions in England. It provides background on Karen Livingstone, the director of the programs. It then outlines key forces shaping global healthcare and describes the 15 Academic Health Science Networks that work locally and nationally to drive innovation adoption across England. The rest of the document details how the Innovation Exchange identifies healthcare needs and supports companies through funding competitions, needs assessments, and providing support to help ready solutions for adoption across the NHS. It provides examples of companies it has supported in areas like patient engagement, chronic condition management, and early disease detection.
EPIS meeting - Dr Derick Mitchell - October 2017ipposi
Derick Mitchell gave a talk on sustaining patient engagement resources through public-private platforms. Some key points:
1. He discussed IPPOSI, a patient-led organization that advocates for patient involvement in health innovation and research.
2. Patient organizations and industry can interact by moving past compliance and instead measuring the value of their interactions through trust and transparency.
3. Generating patient-based evidence through patient registries, mobile apps, and other tools can provide cost-effective, patient-relevant data to inform decision making.
Overview of Kuopio Innovation and Kuopio Science Park, as well as Region's Health Cluster smart speciliation. Senior Advisor Arto Holopainen, Kuopio Innovation Ltd.
Kuopio Innovation is a business developer in Kuopio, Finland that helps innovative organizations through combining ideas, experts, and new ways of thinking. It operates in the Kuopio region, home to the Kuopio Science Park which has over 240 enterprises and around 20,000 people working in fields like health, security, and ICT. Kuopio Innovation provides services like business incubation, helping entrepreneurs develop their ideas and access funding and networks. It also facilitates collaboration between different organizations in the region to foster innovation.
Case Kuopio Living Lab - Sosiaali- ja terveydenhuollon ympäristöt uusien innovaatioiden tukena
Digitaalisaatioasiantuntija Arto Holopainen
Projektipäällikkö Pauliina Kämäräinen
22.5.2018, Jyväskylä
Sosiaali- ja terveydenhuollon ATK-päivät
Kuopio Smart Society, 3.10.2017
Arto Holopainen, Senior Digital Advisor, City of Kuopio
Tiina Arpola, RDI Adviser, Savonia University of Applied Sciences
Kuopion kaupunki ja Kuopion yliopistollinen sairaala (KYS) ovat aloittaneet Living Lab -toiminnan, jolla tulevaisuuden hyvinvointiratkaisuja kehittävät yritykset voivat testata ja kehittää tuotteitaan sekä palveluitaan aidossa terveydenhuollon ympäristössä. Living Labin kautta yritykset saavat tärkeää tietoa ratkaisujensa käytettävyydestä, ja vastaavasti terveydenhuolto saa tietoa uusimpien palveluiden hyödyistä ja mahdollista kustannussäästöistä.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
2. KuopioHealth is a network
of health professionals
committed to advancing
health technology
expertise, research,
business life and
awareness of the area
3. Kuopio University
Hospital Living Lab
From 2016, the KUH Living Lab
project has provided an authentic
testing and research environment
for companies in the most
appropriate departments and
outpatient clinics in the University
Hospital.
The companies involved range
from small start-ups to large
corporations.
Our services include product and
IT innovation and testing, help
with documentation for regulatory
processes, research collaboration
and clinical trials.
One of the five
University Hospitals
in Finland
Specialised medical
care in an area of
248,000 inhabitants
Advanced specialised
medical care in
Eastern and Central
Finland.
4. Kuopio Living Lab
The City of Kuopio has Living Lab
services that companies developing
future healthcare solutions can use
to test and improve their products
and services in an authentic
healthcare environment.
The Living Lab environment is for
primary health care services and is
specialised in geriatric and home
care.
Through Living Lab, companies
receive information about the
usability of their solutions, while
healthcare providers get information
about the benefits of the latest
solutions and their cost-
effectiveness.
One of Finland’s
leading cities in the
fields of health,
wellness and safety
Member of the WHO
Healthy Cities
Network since 2005
Reference site for
European Innovation
Partnership on Active
Healthy Ageing
5. Arto Holopainen | www.kuopiohealth.fi | 29.11.2017
LIVING LAB IN RDI PROCESS
Research
&
Development
Living
Lab
Idea
Sales
&
Marketing
End
user
Development cycles based on feedback
Co-creation with end users
• Customer
needs
• Idea / concept
development
• Product and
service
development
• Regulatory
framework
• Testing in
authentic
environment
• Sales &
Marketing
• Distribution
channels
• Pricing
• Rollout
• Training
• Maintenance
• Futher
development
6. Arto Holopainen | www.kuopiohealth.fi | 29.11.2017
LIVING LAB PROCESS
Plan
•Contact: initial feasibility check (company & testing organisation), feedback within 2 weeks
•Planning: test plan (company)
•Contracts: testing agreement (company & testing organisation)
Test
•Training and communication
•Testing
•Feedback
Evaluate
•Feedback analysing
•Assessment of company’s product
•Evaluation of innovations and activity of the testing organisation
•External communication
7. Arto Holopainen | www.kuopiohealth.fi | 29.11.2017
WWW.KUOPIOHEALTH.FI
CONTACT
1
• COMPANY INFORMATION
• NEEDS AND EXPECTATIONS
FOR COLLABORATION
INPUT
2
• REPONSE WITHIN 2 WEEKS
• INITIAL FEASIBILITY CHECK
RESPONSE
3
HOW TO REACH LIVING LAB?
Fill out contact form
8. Arto Holopainen | www.kuopiohealth.fi | 29.11.2017
LIVING LAB
Q2/2016-Q2/2017
33
Companies
through
Living Lab
79%
(26)
micro
58%
(19)
<5years
(startup)
48%
(16)
Pohjois-Savo
region
39%
(13)
Kuopio
region
9%
(3)
Other than
Finnish
53
Products /
services / ideas
tested
55%
(29)
Kuopio
Living Lab
45%
(24)
KUH
Living Lab
9. Arto Holopainen | www.kuopiohealth.fi | 29.11.2017
COMPANIES NEEDS FOR LIVING LAB?
30,30%
39,40%
63,60%
72,70%
Clinical trials
Test run
Co-creation in the development phase
Testing products and services
*Living Lab survey during Future Care 2017 (n=35)